bluebird bio, Inc. (BLUE)
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Address
455 GRAND UNION BOULEVARD
SOMERVILLE, MA 02145
Founded
1992
Number of Employees
375
Website
http://www.bluebirdbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)